Cargando…

Hematologic Complications of Immune Checkpoint Inhibitors

Immune checkpoint inhibitors have improved outcomes for patients with numerous hematological and solid cancers. Hematologic toxicities have been described, but the spectrum, timing, and clinical presentation of these complications are not well understood. We used the World Health Organization's...

Descripción completa

Detalles Bibliográficos
Autores principales:	Davis, Elizabeth J., Salem, Joe‐Elie, Young, Arissa, Green, Jennifer R., Ferrell, P. Brent, Ancell, Kristin K., Lebrun‐Vignes, Benedicte, Moslehi, Javid J., Johnson, Douglas B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2019
Materias:	Immune‐Related Adverse Events
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6516131/ https://www.ncbi.nlm.nih.gov/pubmed/30819785 http://dx.doi.org/10.1634/theoncologist.2018-0574

Ejemplares similares

Diagnosis and Management of Hepatitis in Patients on Checkpoint Blockade
por: Reynolds, Kerry, et al.
Publicado: (2018)

Late‐Onset Immunotherapy Toxicity and Delayed Autoantibody Changes: Checkpoint Inhibitor–Induced Raynaud's‐Like Phenomenon
por: Khan, Shaheen, et al.
Publicado: (2020)

A Case of Nivolumab‐Induced Bullous Pemphigoid: Review of Dermatologic Toxicity Associated with Programmed Cell Death Protein‐1/Programmed Death Ligand‐1 Inhibitors and Recommendations for Diagnosis and Management
por: Lopez, Adriana T., et al.
Publicado: (2018)

Association between incidental statin use and skeletal myopathies in patients treated with immune checkpoint inhibitors
por: Drobni, Zsofia D, et al.
Publicado: (2021)

Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study
por: Johnson, Douglas B., et al.
Publicado: (2019)

Increased Reporting of Immune Checkpoint Inhibitor–Associated Diabetes
por: Wright, Jordan J., et al.
Publicado: (2018)

Immune Checkpoint Inhibitor Myocarditis Treatment Strategies and Future Directions
por: Moslehi, Javid, et al.
Publicado: (2022)

Onset of Transient Sadness Following the Concomitant Use of a Triptan and Selective Serotonin Reuptake Inhibitor/Serotonin Norepinephrine Reuptake Inhibitors Therapy: A Case Report
por: Meng, Yuki, et al.
Publicado: (2021)

Graft Versus Host Disease Associated with Immune Checkpoint Inhibitors: A Pharmacovigilance Study and Systematic Literature Review
por: Nguyen, Lee S., et al.
Publicado: (2021)

Cardiotoxicity Associated with Gemcitabine: Literature Review and a Pharmacovigilance Study
por: Hilmi, Marc, et al.
Publicado: (2020)

Drug-associated hyperammonaemia: a Bayesian analysis of the WHO Pharmacovigilance Database
por: Balcerac, Alexander, et al.
Publicado: (2022)

Circulating immune checkpoints predict heart failure outcomes
por: Screever, Elles M., et al.
Publicado: (2023)

Skin dendritic cells in melanoma are key for successful checkpoint blockade therapy
por: Prokopi, Anastasia, et al.
Publicado: (2021)

Systematic analysis of drug-associated myocarditis reported in the World Health Organization pharmacovigilance database
por: Nguyen, Lee S., et al.
Publicado: (2022)

Immune-checkpoint inhibitors: long-term implications of toxicity
por: Johnson, Douglas B., et al.
Publicado: (2022)

Impact of body composition on outcomes from anti-PD1 +/− anti-CTLA-4 treatment in melanoma
por: Young, Arissa C, et al.
Publicado: (2020)

CD22 CAR T-cell associated hematologic toxicities, endothelial activation and relationship to neurotoxicity
por: Jess, Jennifer, et al.
Publicado: (2023)

Reversal of immune-checkpoint inhibitor fulminant myocarditis using personalized-dose-adjusted abatacept and ruxolitinib: proof of concept
por: Nguyen, Lee S, et al.
Publicado: (2022)

SPLIT-DOSING OF COVID-19 VACCINES IS SAFE AND PROVIDES NON-INFERIOR ANTIBODY RESPONSIVENESS TO CONVENTIONAL VACCINE DOSING
por: Musa, A., et al.
Publicado: (2022)

Immune checkpoint inhibitor-induced diabetes mellitus with nivolumab
por: Zand Irani, Anis, et al.
Publicado: (2023)

Immune checkpoint inhibitor lichenoid eruption due to pembrolizumab
por: McCormick, Benjamin Joseph, et al.
Publicado: (2023)

Future role for adoptive T-cell therapy in checkpoint inhibitor-resistant metastatic melanoma
por: Borch, Troels Holz, et al.
Publicado: (2020)

First immunotherapeutic CAR-T cells against the immune checkpoint protein HLA-G
por: Anna, François, et al.
Publicado: (2021)

Imatinib-induced pleural effusion: A case report
por: Banka, R, et al.
Publicado: (2017)

Lansoprazole-Induced Thrombocytopenia in a Critically Ill Patient: A Case Report
por: Saad, Mohamed, et al.
Publicado: (2019)

Lenalidomide-induced focal myocarditis mimicking acute ST segment elevation myocardial infarction
por: Tse, Yiu-Hei, et al.
Publicado: (2021)

Unexpected bradycardia after a first dose of doxazosin
por: Pigot, James Edward, et al.
Publicado: (2022)

Insufficiency of compound immune checkpoint blockade to overcome engineered T cell exhaustion in pancreatic cancer
por: Stromnes, Ingunn M, et al.
Publicado: (2022)

(68)Ga-DOTATOC PET/CT to detect immune checkpoint inhibitor-related myocarditis
por: Boughdad, Sarah, et al.
Publicado: (2021)

CD5 levels define functionally heterogeneous populations of naïve human CD4(+) T cells
por: Sood, Aditi, et al.
Publicado: (2021)

Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types
por: Kverneland, Anders Handrup, et al.
Publicado: (2021)

117. COVID-19 Youth Impact Survey: The effects of COVID-19 on Youth Experiencing Homelessness
por: Auerswald, Colette, et al.
Publicado: (2022)

116. Conducting an Online Survey of Youth Experiencing Homelessness During the COVID-19 Pandemic Employing Youth Participatory Action Research: Lessons Learned
por: Auerswald, Colette, et al.
Publicado: (2022)

Heparanase Blockade as a Novel Dual-Targeting Therapy for COVID-19
por: Xiang, Jingyu, et al.
Publicado: (2022)

Acute Kidney Injury Associated With Lopinavir/Ritonavir Combined Therapy in Patients With COVID-19
por: Binois, Yannick, et al.
Publicado: (2020)

Clinical efficacy of T-cell therapy after short-term BRAF-inhibitor priming in patients with checkpoint inhibitor-resistant metastatic melanoma
por: Borch, Troels Holz, et al.
Publicado: (2021)

Inflammatory Biomarkers to Detect Immune Checkpoint Inhibitor-Associated Cardiotoxicity in Lung Cancer Patients: Ready for Prime Time?
por: Aras, Mandar A., et al.
Publicado: (2020)

COVID-19 and immune checkpoint inhibitors: initial considerations
por: Sullivan, Ryan J, et al.
Publicado: (2020)

Welcoming words
por: Garcia Tello, Pablo
Publicado: (2017)

Challenge Based Innovation Introduction
por: Bragós, Ramon, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4cqcu793lvb3s882rdd620tv7e